Physician profile
John William Kelly
NPI 1457305211
$7,576.05
in general payments reported to CMS, 2019-2025
18 companies · $41.76 in 2025
The $41.76 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $5,777 · 2021: $102 · 2022: $486 · 2023: $424 · 2024: $292 · 2025: $41.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $5,688.32 | 2020 | |
| Merck Sharp & Dohme LLC | $480.91 | 2019-2024 | Dificid, Recarbrio, Zerbaxa |
| Gilead Sciences, INC. | $322.24 | 2019-2024 | |
| Viiv Healthcare Company | $174.85 | 2019-2024 | Dovato |
| Paratek Pharmaceuticals, INC. | $151.32 | 2019-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $140.87 | 2022-2024 | Rezzayo, Vabomere, Kimyrsa |
| Insmed, INC. | $132.52 | 2019-2024 | Arikayce |
| Astellas Pharma US INC | $107.22 | 2019-2023 | Cresemba |
| Abbvie INC. | $85.18 | 2021-2025 | |
| Modernatx, INC. | $76.47 | 2023 | Moderna Covid-19 Vaccine |
| Mylan Specialty L.P. | $53.70 | 2020-2022 | |
| Tetraphase Pharmaceuticals, INC. | $38.21 | 2019 | |
| La Jolla Pharmaceutical Company | $33.49 | 2022-2024 | Xacduro |
| Mallinckrodt Hospital Products INC. | $25.91 | 2025 | Terlivaz |
| Janssen Scientific Affairs, LLC | $19.67 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $16.21 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $15.84 | 2022 | |
| Janssen Biotech, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.